Your browser doesn't support javascript.
loading
BET inhibition as a new strategy for the treatment of gastric cancer.
Montenegro, Raquel C; Clark, Peter G K; Howarth, Alison; Wan, Xiao; Ceroni, Alessandro; Siejka, Paulina; Nunez-Alonso, Graciela A; Monteiro, Octovia; Rogers, Catherine; Gamble, Vicki; Burbano, Rommel; Brennan, Paul E; Tallant, Cynthia; Ebner, Daniel; Fedorov, Oleg; O'Neill, Eric; Knapp, Stefan; Dixon, Darren; Müller, Susanne.
Afiliación
  • Montenegro RC; The Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK.
  • Clark PG; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7FZ, UK.
  • Howarth A; Federal University of Pará, Institute of Biological Sciences, Belém, Pará 66075-110, Brazil.
  • Wan X; Department of Chemistry, Chemistry Research Laboratory, University of Oxford, Oxford OX1 3TA, UK.
  • Ceroni A; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7FZ, UK.
  • Siejka P; CRUK/MRC Oxford Institute of Radiation Biology, University of Oxford, Headington OX3 7DQ, UK.
  • Nunez-Alonso GA; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7FZ, UK.
  • Monteiro O; The Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK.
  • Rogers C; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7FZ, UK.
  • Gamble V; The Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK.
  • Burbano R; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7FZ, UK.
  • Brennan PE; The Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK.
  • Tallant C; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7FZ, UK.
  • Ebner D; The Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK.
  • Fedorov O; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7FZ, UK.
  • O'Neill E; The Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK.
  • Knapp S; Target Discovery Institute, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7FZ, UK.
  • Dixon D; Federal University of Pará, Institute of Biological Sciences, Belém, Pará 66075-110, Brazil.
  • Müller S; The Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford, Headington, Oxford OX3 7DQ, UK.
Oncotarget ; 7(28): 43997-44012, 2016 Jul 12.
Article en En | MEDLINE | ID: mdl-27259267
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azepinas / Factores de Transcripción / Triazoles / Proteínas Nucleares / Proliferación Celular / Isoxazoles Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do sul / Brasil Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azepinas / Factores de Transcripción / Triazoles / Proteínas Nucleares / Proliferación Celular / Isoxazoles Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: America do sul / Brasil Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Reino Unido